PATRUNO, CARLO
 Distribuzione geografica
Continente #
NA - Nord America 704
AS - Asia 468
EU - Europa 300
SA - Sud America 118
AF - Africa 26
OC - Oceania 3
Totale 1.619
Nazione #
US - Stati Uniti d'America 667
SG - Singapore 203
BR - Brasile 92
CN - Cina 81
HK - Hong Kong 68
DE - Germania 55
VN - Vietnam 47
FR - Francia 41
RU - Federazione Russa 40
SE - Svezia 37
IT - Italia 36
GB - Regno Unito 24
FI - Finlandia 22
MX - Messico 18
CA - Canada 17
IN - India 16
PL - Polonia 11
ES - Italia 10
BD - Bangladesh 9
AR - Argentina 8
IQ - Iraq 8
ID - Indonesia 6
LT - Lituania 6
TR - Turchia 6
CO - Colombia 5
JP - Giappone 5
ZA - Sudafrica 5
AT - Austria 4
DZ - Algeria 4
SA - Arabia Saudita 4
TN - Tunisia 4
VE - Venezuela 4
AU - Australia 3
EC - Ecuador 3
EG - Egitto 3
PK - Pakistan 3
RO - Romania 3
AE - Emirati Arabi Uniti 2
CI - Costa d'Avorio 2
ET - Etiopia 2
KE - Kenya 2
MY - Malesia 2
NL - Olanda 2
PE - Perù 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
UZ - Uzbekistan 2
AM - Armenia 1
BO - Bolivia 1
BS - Bahamas 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
GF - Guiana Francese 1
GH - Ghana 1
HU - Ungheria 1
IL - Israele 1
JO - Giordania 1
KG - Kirghizistan 1
LB - Libano 1
LY - Libia 1
MA - Marocco 1
NO - Norvegia 1
PH - Filippine 1
PT - Portogallo 1
PY - Paraguay 1
RE - Reunion 1
UA - Ucraina 1
UY - Uruguay 1
Totale 1.619
Città #
Ashburn 114
Singapore 92
San Jose 81
Hong Kong 67
Chandler 34
Dallas 34
Beijing 31
Los Angeles 29
Nyköping 26
Munich 24
Lauterbourg 21
New York 20
Helsinki 16
Fairfield 13
Falkenstein 13
Orem 13
Hanoi 12
Buffalo 10
Chicago 10
Council Bluffs 10
Frankfurt am Main 10
Ho Chi Minh City 10
Houston 10
Mexico City 10
Seattle 10
São Paulo 10
Denver 9
Phoenix 8
Santa Clara 8
Woodbridge 8
Lawrence 7
Montreal 7
Warsaw 7
Wilmington 7
Brooklyn 6
Cambridge 6
Chennai 6
Roxbury 6
Turku 6
Ankara 5
Bari 5
Inglewood 5
London 5
Miami 5
Johannesburg 4
Pescara 4
San Francisco 4
Thái Nguyên 4
Tokyo 4
Xi'an 4
Atlanta 3
Baghdad 3
Des Moines 3
East Gwillimbury 3
Elk Grove Village 3
Haiphong 3
Hyderabad 3
Reston 3
Salt Lake City 3
San Diego 3
Wroclaw 3
Abidjan 2
Addis Ababa 2
Algiers 2
Ann Arbor 2
Belgrade 2
Biên Hòa 2
Brasília 2
Caracas 2
Concord 2
Da Nang 2
Dhaka 2
Fortaleza 2
Fulham 2
Hải Dương 2
Jakarta 2
Kuala Lumpur 2
Lima 2
Limeira 2
Manchester 2
Maricá 2
Medellín 2
Nairobi 2
Najaf 2
Neuilly-sur-Seine 2
Nuremberg 2
Paris 2
Port Saint Lucie 2
Querétaro 2
Quito 2
Raleigh 2
Rio de Janeiro 2
Riyadh 2
Samara 2
Stockholm 2
Tashkent 2
Turin 2
Vitória de Santo Antão 2
Volta Redonda 2
Aachen 1
Totale 980
Nome #
Use of Dupilumab for 543 Adult Patients with Moderate-To-Severe Atopic Dermatitis: A Multicenter, Retrospective Study 141
Patch testing with textile dye mix in Italy: A 2-year multicenter SIDAPA study 108
Myroxylon pereirae (balsam of Peru): Still worth testing? 103
Skin tests in the diagnosis of adverse drug reactions 99
Dupilumab in atopic dermatitis: predictors of treatment outcome and time to response 99
Patch testing of budesonide in Italy: The SIDAPA baseline series experience, 2018–2019 98
Urticaria: Recommendations from the Italian Society of Allergology, Asthma and Clinical Immunology and the Italian Society of Allergological, Occupational and Environmental Dermatology 97
A 52-week update of a multicentre Italian real-world experience on effectiveness and safety of dupilumab in adolescents with moderate-to-severe atopic dermatitis 83
Long-term effectiveness of dupilumab up to 52 weeks in atopic dermatitis in 253 adult patients 79
The new Italian SIDAPA Baseline Series for patch testing (2023): an update according to the new regulatory pathway for contact allergens 69
AtopyReg®, the Prospective Italian Patient Registry for Moderate-to-Severe Atopic Dermatitis in Adults: Baseline Demographics, Disease Characteristics, Comorbidities, and Treatment History 67
Short-term effectiveness and safety of abrocitinib in adults with moderate-to-severe atopic dermatitis: results from a 16-week real-world multicenter retrospective study–il AD (Italian landscape atopic dermatitis) 64
Association between maternal dupilumab exposure and pregnancy outcomes in patients with moderate-to-severe atopic dermatitis: A nationwide retrospective cohort study 62
Contact allergy to SIDAPA baseline series allergens in patients with eyelid dermatitis: An Italian multicentre study 62
Drug Survival of Upadacitinib and Predicting Factors of Discontinuation in Adult Patients Affected by Moderate-to-Severe Atopic Dermatitis: An Italian Multicenter Analysis 61
Clinical outcomes and management of JAK inhibitor-associated acne in patients with moderate-to-severe atopic dermatitis undergoing upadacitinib: A multicenter retrospective study 55
Short-, mid- and long-term efficacy of dupilumab in moderate-to-severe atopic dermatitis: a real-world multicentre Italian study of 2576 patients 55
Effective response to upadacitinib in patients affected by prurigo nodularis and by atopic dermatitis with a predominant prurigo nodularis pattern: A multicenter case series study 53
Frequency of contact allergy to pentylene glycol. Retrospective cross-sectional study with data from the Società Italiana di Dermatologia Allergologica Professionale e Ambientale (SIDAPA) 52
AtopyReg®: the prospective Italian patient registry for moderate to severe atopic dermatitis in adults by SIDeMaST 51
Contact allergy to hydroxyisohexyl 3-cyclohexene carboxaldehyde in Italy: Prevalence, trend, and concordance with fragrance mix II 49
Upadacitinib improves symptoms of concomitant allergic rhinitis or allergic asthma in patients with severe atopic dermatitis: A 16-week multicentre retrospective study 48
Safety of omalizumab in chronic urticaria during pregnancy: a real-life study 46
Totale 1.701
Categoria #
all - tutte 6.697
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.697


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20218 0 0 0 0 0 0 0 0 0 3 3 2
2021/202263 4 0 10 2 3 12 0 2 6 5 9 10
2022/202383 9 21 8 3 3 11 2 13 9 1 2 1
2023/202435 3 8 3 3 6 5 0 3 0 1 1 2
2024/2025330 8 0 6 5 9 27 25 36 10 10 70 124
2025/20261.138 172 76 59 206 166 65 100 35 174 85 0 0
Totale 1.701